Expression of concern
Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A
Paper Information
Record ID:
36324
Author(s):
Journal:
Publication Date:
July 18, 2012
Retraction Date:
December 17, 2021
(3.9 years years ago)
Subjects:
Institutions:
- Department of Physiology, Pharmacology and Neuroscience, City University of New York Medical School, New York, New York 10031
- Department of Biology and Neuroscience, Graduate School of the City University of New York, New York, New York 10016
- Department of Science Education, Hofstra North Shore–Long Island Jewish School of Medicine, Hempstead, New York 11549-1000
- Pain Therapeutics, Inc., Austin, Texas 78731
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Society for Neuroscience
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1523/JNEUROSCI.2306-21.2021Citations (62)
62
Total Citations21
Post-Retraction(33.9%)
40
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
6
Within 1 year
4
After 2+ years
1267
Days since retraction (latest)
The Emerging Role of Filamin A and FLNA Gene in Central Nervous System Functions: Insights into Neurodevelopment and Disease
Nikita I Golushko, A. D. Shevlyakov, Daniil Martynov et al. (6 authors)
Journal of Integrative Neuroscience
Open Access
Published: Jun 2025
1267 days after retraction
Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates
Jana Hroudová, Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Published: Jun 2024
4 citations
4 citations
920 days after retraction
Liquid clues: tear film biomarkers unravelling Alzheimer’s mysteries
Amna Zaheer, Insa Binte Anwar, Abdul Haseeb et al. (4 authors)
Annals of Medicine and Surgery
Open Access
Published: Apr 2024
838 days after retraction
A Systematic Review on Drugs Acting as Nicotinic Acetylcholine Receptor Agonists in the Treatment of Dementia
Alessio Crestini, Elena Carbone, Roberto Rivabene et al. (11 authors)
Cells
Open Access
Published: Jan 2024
9 citations
9 citations
770 days after retraction
Insights to develop tau‐directed therapeutics to protect the synaptic integrity for tauopathies
Eunji Cha, Hak Joong Kim, Sang Min Lim
Bulletin of the Korean Chemical Society
Published: Oct 2023
3 citations
3 citations
672 days after retraction
Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update
Li‐Kai Huang, Yi‐Chun Kuan, Ho-Wei Lin et al. (4 authors)
Journal of Biomedical Science
Open Access
Published: Oct 2023
149 citations
149 citations
654 days after retraction
Simufilam Reverses Aberrant Receptor Interactions of Filamin A in Alzheimer’s Disease
Hoau-Yan Wang, Erika Cecon, Julie Dam et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Sep 2023
14 citations
14 citations
633 days after retraction
Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
Francesca R. Buccellato, Marianna D’Anca, Gianluca Martino Tartaglia et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Sep 2023
55 citations
55 citations
631 days after retraction
Over‐expression of <scp>Dyrk1A</scp> affects bleeding by modulating plasma fibronectin and fibrinogen level in mice
Guillaume Postic, Jean Solarz, Cécile Loubière et al. (16 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Jul 2023
3 citations
3 citations
566 days after retraction
Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes
Hoau-Yan Wang, Zhe Pei, Kuo-Chieh Lee et al. (8 authors)
Frontiers in Aging
Open Access
Published: Jun 2023
7 citations
7 citations
559 days after retraction
Targeting α7 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development
Lindsay H. Burns, Zhe Pei, Hoau‐Yan Wang
Drug Development Research
Published: Jun 2023
27 citations
27 citations
538 days after retraction
Molecular mechanisms and genetics of Alzheimer’s disease
Gözde Öztan, Halim İşsever
Turkish Journal of Biochemistry
Open Access
Published: May 2023
5 citations
5 citations
518 days after retraction
Expression of the primate-specific LINC00473 RNA in mouse neurons promotes excitability and CREB-regulated transcription
Priit Pruunsild, C. Peter Bengtson, Isabel Loss et al. (5 authors)
Journal of Biological Chemistry
Open Access
Published: Apr 2023
9 citations
9 citations
473 days after retraction
Alzheimer’s drug saga prompts journal to scrutinize whistle-blowers
Holly Else
Nature
Open Access
Published: Jan 2023
3 citations
3 citations
391 days after retraction
Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders
Preetpal Kaur, Alisha Khera, Hema Kumari Alajangi et al. (7 authors)
Molecular Neurobiology
Published: Dec 2022
25 citations
25 citations
371 days after retraction
Brain Insulin Resistance, Nitric Oxide and Alzheimer’s Disease Pathology
Zhe Pei, Kuo-Chieh Lee, Amber Khan et al. (4 authors)
BENTHAM SCIENCE PUBLISHERS eBooks
Published: Nov 2022
347 days after retraction
Evidence of Filamin A loss of solubility at the prodromal stage of neuropathologically-defined Alzheimer’s disease
Étienne Aumont, Cyntia Tremblay, Stéphanie Levert et al. (6 authors)
Frontiers in Aging Neuroscience
Open Access
Published: Nov 2022
6 citations
6 citations
342 days after retraction
Direct and Indirect Effects of Filamin A on Tau Pathology in Neuronal Cells
Stéphanie Levert, Julie Pilliod, Étienne Aumont et al. (7 authors)
Molecular Neurobiology
Open Access
Published: Nov 2022
6 citations
6 citations
336 days after retraction
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Zdeněk Fišar
Biomolecules
Open Access
Published: Nov 2022
56 citations
56 citations
329 days after retraction
Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathology
Koyo Tsujikawa, Kohei Hamanaka, Yuichi Riku et al. (31 authors)
Science Advances
Open Access
Published: May 2022
23 citations
23 citations
159 days after retraction
Amyloid-beta Targeted Therapeutic Approaches for Alzheimer’s Disease: Long Road Ahead
Yuxuan Dai, Chenyi Lei, Zhenhao Zhang et al. (6 authors)
Current Drug Targets
Published: Apr 2022
9 citations
9 citations
126 days after retraction
Expression of Concern: Wang et al., “Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A”
Unknown Authors
Journal of Neuroscience
Open Access
Published: Dec 2021
Same day as retraction
Regulation of the HTRA2 Protease Activity by an Inhibitory Antibody-Derived Peptide Ligand and the Influence on HTRA2-Specific Protein Interaction Networks in Retinal Tissues
Carsten Schmelter, Kristian Nzogang Fomo, Natarajan Perumal et al. (5 authors)
Biomedicines
Open Access
Published: Aug 2021
10 citations
10 citations
126 days before retraction
Emodin Prevented Depression in Chronic Unpredicted Mild Stress-Exposed Rats by Targeting miR-139-5p/5-Lipoxygenase
Teng Zhang, Can Yang, Jiang Chu et al. (11 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Jul 2021
17 citations
17 citations
144 days before retraction
Stress Diminishes BDNF-stimulated TrkB Signaling, TrkB-NMDA Receptor Linkage and Neuronal Activity in the Rat Brain
Siobhan Robinson, Allison S. Mogul, Elisa M. Taylor-Yeremeeva et al. (6 authors)
Neuroscience
Open Access
Published: Jul 2021
13 citations
13 citations
149 days before retraction
The function and pathogenic mechanism of filamin A
Jie Zhou, Xinmei Kang, Han‐Xiang An et al. (5 authors)
Gene
Published: Mar 2021
69 citations
69 citations
274 days before retraction
Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer’s disease: a systematic review and meta-analysis
Xulong Ding, Shuting Zhang, Lijun Jiang et al. (6 authors)
Translational Neurodegeneration
Open Access
Published: Mar 2021
42 citations
42 citations
280 days before retraction
Fil-lamin-ing in the Gap in Cortical Dysplasia
Christina Groß
Epiliepsy currents/Epilepsy currents
Open Access
Published: Dec 2020
379 days before retraction
Filamin A inhibition reduces seizure activity in a mouse model of focal cortical malformations
Longbo Zhang, Tianxiang Huang, Shannon Teaw et al. (8 authors)
Science Translational Medicine
Open Access
Published: Feb 2020
43 citations
43 citations
667 days before retraction
PTI-125 REDUCES BIOMARKERS OF ALZHEIMER’S DISEASE IN PATIENTS
H.-Y. Wang, Zhen‐Ming Pei, K.-C. Lee et al. (10 authors)
The Journal of Prevention of Alzheimer s Disease
Published: Jan 2020
35 citations
35 citations
716 days before retraction
Aβ42-α7-like nicotinic acetylcholine receptors and Alzheimer’s disease
Hoau-Yan Wang, Amber Khan
Elsevier eBooks
Published: Jan 2020
2 citations
2 citations
716 days before retraction
Insulin and adipokine signaling and their cross-regulation in postmortem human brain
Hoau-Yan Wang, Ana W. Capuano, Amber Khan et al. (9 authors)
Neurobiology of Aging
Open Access
Published: Aug 2019
7 citations
7 citations
850 days before retraction
NMDA receptor modulation of glutamate release in activated neutrophils
Ana Gutierrez del Arroyo, Anna Hadjihambi, Jenifer Sanchez et al. (11 authors)
EBioMedicine
Open Access
Published: Aug 2019
22 citations
22 citations
862 days before retraction
Hippocampal gene expression patterns linked to late-life physical activity oppose age and AD-related transcriptional decline
Nicole C. Berchtold, G. Aleph Prieto, Michael Phelan et al. (8 authors)
Neurobiology of Aging
Open Access
Published: Feb 2019
40 citations
40 citations
1030 days before retraction
S-nitrosylation of E3 ubiquitin-protein ligase RNF213 alters non-canonical Wnt/Ca+2 signaling in the P301S mouse model of tauopathy
Haitham Amal, Guanyu Gong, Elizabeta Gjoneska et al. (7 authors)
Translational Psychiatry
Open Access
Published: Jan 2019
51 citations
51 citations
1053 days before retraction
Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting
Yao Zhang, Jia‐Zhao Xie, Xiangyang Xu et al. (8 authors)
Neuroscience Bulletin
Open Access
Published: Jan 2019
34 citations
34 citations
1072 days before retraction
Overview of Therapeutic Efficacy of Mushrooms
Sindhu Ramesh, Mohammed Majrashi, Mohammed Almaghrabi et al. (13 authors)
Springer eBooks
Published: Jan 2019
7 citations
7 citations
1081 days before retraction
A model of lipid dysregulation and altered nutrient status in Alzheimer's disease
Keith Fluegge
Alzheimer s & Dementia Translational Research & Clinical Interventions
Open Access
Published: Jan 2019
7 citations
7 citations
1081 days before retraction
Drugs for Targeted Therapies of Alzheimer’s Disease
Chit Tam, Jack Ho Wong, Tzi Bun Ng et al. (5 authors)
Current Medicinal Chemistry
Published: May 2018
15 citations
15 citations
1326 days before retraction
Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer’s disease
Lindsay H. Burns, Hoau-Yan Wang
Neuroimmunology and Neuroinflammation
Open Access
Published: Dec 2017
25 citations
25 citations
1470 days before retraction
RETRACTED ARTICLE: Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer’s disease pathogenesis
Hoau-Yan Wang, Caryn Trocme‐Thibierge, Andres Stucky et al. (15 authors)
Alzheimer s Research & Therapy
Open Access
Published: Jul 2017
14 citations
14 citations
1604 days before retraction
PTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer's disease pathogenesis
Hoau-Yan Wang, Kuo-Chieh Lee, Zhe Pei et al. (6 authors)
Neurobiology of Aging
Published: Mar 2017
38 citations
38 citations
1722 days before retraction
Paper citing Reducing Amyloid-Related Alzheimer's Disease Patho...
Unknown Authors
Unknown Journal
Published: Feb 2017
1765 days before retraction
Extranuclear partners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis
Gabriella Castoria, Ferdinando Auricchio, Antimo Migliaccio
The FASEB Journal
Published: Dec 2016
46 citations
46 citations
1815 days before retraction
Prenatal Cocaine Exposure Upregulates BDNF-TrkB Signaling
Andres Stucky, Kalindi Bakshi, Eitan Friedman et al. (4 authors)
PLoS ONE
Open Access
Published: Aug 2016
18 citations
18 citations
1960 days before retraction
α7-Nicotinic Acetylcholine Receptors: New Therapeutic Avenues in Alzheimer’s Disease
Murat Öz, Georg Petroianu, Dietrich E. Lorke
Neuromethods
Published: Jan 2016
8 citations
8 citations
2177 days before retraction
Cross-talk between androgen receptor/filamin A and TrkA regulates neurite outgrowth in PC12 cells
Marzia Di Donato, Antonio Bilancio, Loredana D’Amato et al. (11 authors)
Molecular Biology of the Cell
Open Access
Published: Jun 2015
42 citations
42 citations
2381 days before retraction
Emerging drug targets for A<b>β</b> and tau in Alzheimer's disease: a systematic review
Sophie West, Praveen Bhugra
British Journal of Clinical Pharmacology
Open Access
Published: Mar 2015
47 citations
47 citations
2478 days before retraction
Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment
Sylvia Lombardo, Uwe Maskos
Neuropharmacology
Open Access
Published: Dec 2014
277 citations
277 citations
2561 days before retraction
Link Between Chronic Bacterial Inflammation and Alzheimer Disease
Fehmida Bibi, Muhammad Yasir, Sayed Sartaj Sohrab et al. (8 authors)
CNS & Neurological Disorders - Drug Targets
Published: Sep 2014
45 citations
45 citations
2647 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #36325
Nov 10, 2021Quick Stats
Total Citations:
62
Years Since Retraction:
3.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025